KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Cost of Revenue (2016 - 2025)

Eli Lilly's Cost of Revenue history spans 17 years, with the latest figure at $3.4 billion for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 40.28% year-over-year to $3.4 billion; the TTM value through Dec 2025 reached $11.1 billion, up 31.29%, while the annual FY2025 figure was $11.1 billion, 31.29% up from the prior year.
  • Cost of Revenue reached $3.4 billion in Q4 2025 per LLY's latest filing, up from $3.0 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $3.4 billion in Q4 2025 to a low of $1.4 billion in Q2 2022.
  • Average Cost of Revenue over 5 years is $2.0 billion, with a median of $1.9 billion recorded in 2021.
  • Peak YoY movement for Cost of Revenue: soared 59.84% in 2021, then fell 26.76% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $2.1 billion in 2021, then dropped by 24.49% to $1.5 billion in 2022, then rose by 15.48% to $1.8 billion in 2023, then surged by 34.44% to $2.4 billion in 2024, then soared by 40.28% to $3.4 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Cost of Revenue are $3.4 billion (Q4 2025), $3.0 billion (Q3 2025), and $2.4 billion (Q2 2025).